Colorectal Cancer Association of Canada - CCAC

News and Resources > Latest News  


FDA Approves Oral Drug Lonsurf For Patients With Advanced Colon Cancer

After years of trying, the drug Lonsurf is finally deemed useable to treat patients with advanced colorectal cancer.

On Sept. 22, the Food and Drug Administration (FDA) announced the approval of using Lonsurf, a combination of drugs manufactured by the Taiho Oncology Inc., to treat colorectal cancer tumors that no longer respond to other forms of therapy.

« More